Manassas, Va. – ATCC, the premier biological materials resource and standards organization, today announced the appointment of its next President, Dr. Brian A. Pollok, former Chief Scientific Officer and Head of Global Research and Development for Life Technologies Corporation, Carlsbad, CA. Dr. Raymond H. Cypess, Executive CEO and Chairman of the Board, will continue to provide leadership and support during the transitional period.

Dr. Pollok’s impressive career includes Vice President of R&D with Invitrogen’s Discovery Sciences in Madison, Wisconsin; Senior Vice President of Research and Co-Founder of Ansata Therapeutics, Inc., La Jolla, CA; Vice President of Discovery Research at Aurora Biosciences/Vertex Pharmaceuticals Inc., San Diego, CA; Senior Research Investigator for Pfizer, Groton, CT; and Assistant Professor of Microbiology and Immunology at Wake Forest University. Dr. Pollok received his B.A. in biology and chemistry from the University of Virginia; his Ph.D. from the University of Alabama in Birmingham; and he completed his postdoctoral fellowship while at the Fox Chase Cancer Center.

“After a long and dedicated search,” says Executive CEO, Dr. Raymond Cypess, “we are delighted to have selected such a well-respected research and development scientist bringing both academic and industry experience to guide the organization.”

Dr. Pollok’s appointment is occurring at a time of growth and opportunities for ATCC. “This position promises to provide both unique challenges and exciting opportunities,” says Dr. Pollok. “It is an honor to lead an organization with such an outstanding reputation, particularly one which has directly enabled my own scientific contributions.”

The combination of executive leadership and scientific talent that both Dr. Cypess and Dr. Pollok possess will result in a formidable transition team to uphold the ATCC mission and ensure that ATCC continues to meet and exceed the expectations of its customers as has been its tradition for the past eighty-six years.

ABOUT ATCC

ATCC provides research and development tools and reagents as well as related biological material management services, consistent with its mission: to acquire, authenticate, preserve, develop, and distribute standard reference microorganisms, cell lines, and related materials for research in the life sciences.

With distribution to more than 140 countries and a working relationship with 12 distribution partners, we have the experience, knowledge, rigorous methodologies, standards, longevity and the global reach to serve academic institutions, government agencies, biotech, biopharma, and research organizations around the world.

For more information, visit www.atcc.org.